Stamatis Karakatsanis

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Maria K. Angelopoulou et al. · Annals of Hematology · 2021 · 26 citations

Medicine, Nuclear Medicine, Oncology +16

Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP

Theodoros P. Vassilakopoulos, Michail Michail, Sotirios G. Papageorgiou et al. · The Oncologist · 2021 · 26 citations · Full text

Medicine, Oncology, Chemotherapy +14

Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system

Panagiotis Diamantopoulos, Ιoannis Kotsianidis, Argiris Symeonidis et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 25 citations

Medicine, Hematology, Oncology +15

A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria

Maria Siopi, Stamatis Karakatsanis, Christoforos Roumpakis et al. · Journal of Fungi · 2021 · 18 citations · Full text

Life Sciences, Hematology, Microbiology +16

Evaluation of the Dynamiker® Fungus (1–3)-β-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies

Maria Siopi, Stamatis Karakatsanis, Christoforos Roumpakis et al. · Infectious Diseases and Therapy · 2022 · 13 citations · Full text

Medicine, Hematology, Microbiology +17